Related Experiment Video
Updated: Apr 19, 2026

A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
Molecular pathways: microRNAs, cancer cells, and microenvironment
Ioana Berindan-Neagoe1, George A Calin2
1Research Center for Functional Genomics and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. Department of Immunology, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. Department of Functional Genomics and Experimental Pathology, "Ion Chiricuta" The Oncology Institute, Cluj-Napoca, Romania. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. gcalin@mdanderson.org ioana.neagoe@umfcluj.ro.
Abstract:
One of the most unexpected discoveries in molecular oncology over the last decade is the interplay between abnormalities in protein-coding genes and short noncoding microRNAs (miRNA) that are causally involved in cancer initiation, progression, and dissemination. This phenomenon was initially defined in malignant cells; however, in recent years, more data have accumulated describing the active participation of miRNAs produced by microenvironment cells. As hormones, miRNAs can be released by a donor cell in various forms of vesicles or as "free" molecules secreted by active mechanisms. These miRNAs spread as signaling molecules that are uptaken either as exosomes or as "free" RNAs, by cells located in other parts of the organism. Here, we discuss the communication between cancer cells and the microenvironment through miRNAs. We further expand this in a more translational context and present miRNAs as predictors of treatment response, as crucial agents in targeted therapeutics, and as significant molecules to target.
Insights
MicroRNAs (miRNAs) are key players in cancer, influencing tumor growth and spread. These small molecules mediate communication between cancer cells and their environment, impacting treatment outcomes.
Area of Science:
- Molecular Oncology
- Cancer Biology
- RNA Biology
Background:
- Recent discoveries highlight the interplay between genetic mutations and microRNAs (miRNAs) in cancer.
- MicroRNAs (miRNAs) are increasingly recognized for their roles beyond cancer cells, originating from the tumor microenvironment.
- Extracellular miRNAs function as signaling molecules, transported via vesicles or as free molecules.
Purpose of the Study:
- To review the role of microRNAs (miRNAs) in cancer cell-microenvironment communication.
- To explore the translational applications of miRNAs in oncology.
- To discuss miRNAs as biomarkers for treatment response and therapeutic targets.
Main Methods:
- Literature review and synthesis of current research on miRNA-mediated communication in cancer.
- Analysis of studies investigating extracellular miRNA transport and uptake.
- Examination of clinical data and preclinical models related to miRNA therapeutics.
Main Results:
- MicroRNAs (miRNAs) facilitate intercellular communication, influencing cancer initiation, progression, and metastasis.
- Extracellular miRNAs, packaged in vesicles or as free molecules, act as systemic signaling agents.
- Evidence supports miRNAs' potential as predictive biomarkers for therapeutic efficacy.
Conclusions:
- MicroRNA-mediated communication is a critical aspect of the tumor microenvironment.
- MicroRNAs hold significant promise as predictive biomarkers and therapeutic targets in oncology.
- Targeting miRNAs offers a novel strategy for cancer treatment.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

